1. Berman E, Raymond V, Daghestani A, Arlin ZA, Gee TS, Kempin S, Hancock C,Williams L, StevensYW, Clarkson BD,Young C (1989) 4-Demethoxydaunorubicin (Idarubicin) in combination with 1-b-D-arabinofuranosylcytosine in the treatment of relapsed or refractory acute leukemia. Cancer Res 49: 477–481
2. Berman E, Raymond V, Gee T, Kempin SJ, Gulati S, Andreeff M, Kolitz J, Gabrilove J, Heller G, Young CW, Clarkson BD (1989) Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering cancer center. Semin Oncol 16 [Suppl 2]: 30–34
3. Buechner T, Hiddeman W, Koenigsmann M, Zuehlsdorf M,Woermann B, Boeckmann A, Aguion Freire E, Innig G, Maschmeyer G, Ludwig W, Sauerland C, Schulz G (1990) Recombinant human GM-CSF following chemotherapy in high-risk AML. Bone Marrow Transplantation 6 [Supp 1], 131–133
4. Carella AM, Martinengo M, Santini G, Gaozza E, Damasio E, Giordano D, Nati S, Congiu A, Cerri R, Risso M, Ganzina F, Marmont AM (1987) Idarubicin in combination with etoposide and cytarabine in adult untreated acute non lymphoblastic leukemia. Eur J Cancer Clin Oncol 23: 1673–1678
5. Carella AM, Berman E, Maraone MP, Ganzina F (1990) Idarubicin in the treatment of acute leukemias. An overview of preclinical and clinical studies. Haematologica 75: 159–169